跳至主要内容
临床试验/NCT04581122
NCT04581122招募中不适用

Zhongshan Hospital

Shanghai Zhongshan Hospital1 个研究点 分布在 1 个国家目标入组 1,500 人开始时间: 2020年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,500
试验地点
1
主要终点
overall survival (OS)

研究概览

简要总结

A multiple-center study on the effect of different ways of lymph node dissection on the prognosis of less than 3cm ground glass nodules with more than solid components

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged between 18 and 75 years;
  • GGO is diagnosed by lung CT and failure to subside after 3 months (the patient having been re-examined by thin-section CT);
  • The maximum diameter of the GGO is smaller than 3cm;
  • The maximum diameter of the solid component in the GGO is more than 50%;
  • The patient is able to undergo the lobectomy
  • The patient is able to understand and comply with the study and has provided written informed consent.

排除标准

  • Patients meeting any of the following criteria are not eligible for this trial:
  • Patients with a history of using immunosuppressive or hormonal drugs;
  • Patients receiving radiotherapy or chemotherapy;
  • Patients who fail to comply with our follow-up strategy;
  • Other situations that are not in conformity with the standards and requirements of this trial.

结局指标

主要结局

overall survival (OS)

时间窗: 5 years

five year overall survival

次要结局

未报告次要终点

研究者

发起方
Shanghai Zhongshan Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验